Formulation and Evaluation of Gastroretentive Floating Dosage Forms of Clarithromycin
[...]no adverse effects due to floating devices have been reported to date3. [...]it can be concluded from Fig.1 as the concentration of NaHCo3 increases the floating lag time decreases and floating time increases. [...]the concentration of polymer was increased to 8% for batch FHM2, which showed ma...
Gespeichert in:
Veröffentlicht in: | Research journal of pharmacy and technology 2019-04, Vol.12 (4), p.1510-1516 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [...]no adverse effects due to floating devices have been reported to date3. [...]it can be concluded from Fig.1 as the concentration of NaHCo3 increases the floating lag time decreases and floating time increases. [...]the concentration of polymer was increased to 8% for batch FHM2, which showed matrix integrity, but the release of drug was too rapid. [...]HPMC is a suitable polymer for the development of gastric floating drug delivery systems. |
---|---|
ISSN: | 0974-3618 0974-360X 0974-306X |
DOI: | 10.5958/0974-360X.2019.00250.6 |